{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:14:50Z","timestamp":1793672090044,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.clinthera.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T10:08:30Z","timestamp":1371809310000},"page":"772-779","source":"Crossref","is-referenced-by-count":66,"title":["A Stewardship Program\u2019s Retrospective Evaluation of Vancomycin AUC24\/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis"],"prefix":"10.1016","volume":"35","author":[{"given":"Kristen M.","family":"Gawronski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jack Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina M.","family":"Khadem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karri A.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.05.008_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.130.4.947","article-title":"Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices","volume":"130","author":"Jeffres","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.008_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib3","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003;31:481\u2013498","DOI":"10.1016\/j.ajic.2003.09.002"},{"key":"10.1016\/j.clinthera.2013.05.008_bib4","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/JCM.00154-08","article-title":"Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit","volume":"46","author":"Chua","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2013.05.008_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1592\/phco.27.7.1001","article-title":"Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes","volume":"27","author":"Lodise","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2013.05.008_bib6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.05.008_bib7","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.008_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2013.05.008_bib9","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1086\/598186","article-title":"Staphylococcus aureus bloodstream infections: definitions and treatment","volume":"48","author":"Corey","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/596731","article-title":"Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?","volume":"30","author":"Ben-David","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2013.05.008_bib11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/656623","article-title":"An antimicrobial stewardship program's impact","volume":"51","author":"Bauer","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.05.008_bib13","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":"Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections","volume":"34","author":"Berthoin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2013.05.008_bib15","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.05.008_bib16","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/491714","article-title":"The role of vancomycin in the treatment paradigm","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.05.008_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.05609-11","article-title":"Vancomycin AUC24\/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization","volume":"56","author":"Brown","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.05.008_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","article-title":"Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia","volume":"47","author":"Garazzino","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.05.008_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.32.9.1320","article-title":"Vancomycin concentrations in infected and noninfected human bone","volume":"32","author":"Graziani","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.05.008_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/AAC.32.6.848","article-title":"Vancomycin pharmacokinetics in patients with various degrees of renal function","volume":"32","author":"Rodvold","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.05.008_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/AAC.22.3.391","article-title":"Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations","volume":"22","author":"Rotschafer","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.05.008_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.31.3.393","article-title":"Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers","volume":"31","author":"Healy","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.05.008_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/clpt.1988.74","article-title":"Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects","volume":"43","author":"Golper","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.05.008_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1207\/S15324796ABM2603_02","article-title":"Classification and regression tree analysis in public health: methodological review and comparison with logistic regression","volume":"26","author":"Lemon","year":"2003","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.clinthera.2013.05.008_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jama.2011.72","article-title":"Hospital readmission as an accountability measure","volume":"305","author":"Axon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.05.008_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can't get there from here","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.05.008_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","article-title":"Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy","volume":"37","author":"Wong-Beringer","year":"2011","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813002440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813002440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T23:30:32Z","timestamp":1539559832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0149291813002440"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.05.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}